Exhibit 99.1
| |
NEWS RELEASE | ![[exhibit991001.jpg]](https://capedge.com/proxy/8-K/0001515971-13-000227/exhibit991001.jpg)
|
| |
FOR IMMEDIATE RELEASE
ISATORI, INC. REPORTS FIRST QUARTER OPERATING RESULTS
HIGHLIGHTS OF QUARTER INCLUDE LAUNCH OF NEW PRODUCTS,
UPGRADE OF INTERNET MARKETING INFRASTRUCTURE, AND
CONTINUED PROGRESS IN MASS-MARKET EXPANSION
GOLDEN, CO (MarketWired, May 15, 2013) --iSatori, Inc. (OTCQB: IFIT),an emerging leader in the development and marketing of scientifically engineered nutritional supplements for healthier lifestyles, today announced its first quarter 2013 financial results, which are summarized in the following table. A complete report of the Company’s financial results will be available via its Form 10-Q quarterly report filed with the Securities and Exchange Commission today.
iSatori, Inc.
Comparative Summary of First Quarter Results
for 2013 and 2012 ($000’s)
| | |
| First Quarter: March 31 |
| 2013 | 2012 |
Gross Sales1 | $2,919 | $2,796 |
Operating Profit (Loss) | <$81> | $297 |
Pre-Tax Profit (Loss) per GAAP | <$253> | $668 |
Less: Product Line Divestiture2 | N/A | <$500> |
Less: Derivative Valuation3 | <$230> | <$16> |
Non-GAAP Pre-Tax Profit (Loss) | <$23> | $184 |
1
Does not include cost of returns, promotions, coupons, or other sales discounts used to calculate net sales in accordance with GAAP. Net Sales for the period were $2.204 million and $2.445 million for 2013 and 2012 respectively; please see Company’s quarterly SEC report on Form 10-Q as mentioned above.
2
Excludes gain of $500,000 realized in Quarter 1 of 2012 upon the sale of dormant children’s vitamin product line by iSatori.
3
Excludes non-cash net effect of valuation of various derivatives.
Gross sales (non-GAAP) of approximately $2.9 million for the quarter ended March 31, 2013, compared with first quarter 2012 gross sales of approximately $2.8 million. The Company’s pre-tax loss (GAAP) for the 2013 first quarter of <$253,000> did not include the benefit of a $500,000 gain realized by the Company in the first quarter of 2012 upon its sale of a dormant product line. A non-GAAP pre-tax loss of <$23,000> in the first quarter of 2013 can be compared with a non-GAAP pre-tax income of $184,000 in the first quarter of 2012. Non-GAAP results for both 2013 and 2012 exclude (1) the one-time gain of $500,000 from a product line divestiture in 2012 and (2) the non-cash net effect of valuation of various derivatives in both years.
Commenting on the Company’s financial results, Stephen Adele, Founder and CEO of iSatori, noted, “2013 is developing into an exciting year for iSatori as we proceed with our expansion into the mass market and continue to develop and launch new, category-defining nutritional supplements. While our first quarter 2013 financial results continued to reflect certain costs related to these investments, we are very excited about the growth opportunities available to the Company during the balance of the year and beyond. Our optimism regarding the future revolves around a number of strategic initiatives we began implementing during the second half of 2012.
“Specifically, we have successfully upgraded our Internet marketing infrastructure in a manner that has increased our customer response rate and is expected to lead to improved customer loyalty and higher lifetime values in our direct-to-consumer marketing programs. We have also accelerated our research and development activities to achieve our goal of introducing at least four new products annually. During the past three months, we have already launched two successful nutritional supplement products into the specialty and wholesale markets. Finally, we achieved major breakthroughs in our ‘mass market’ expansion initiative with our entry into Walgreens and Duane Reade, which are now carrying our time-released Energize tablets in over 6,700 drugstores throughout the United States. Our objective is to establish relationships with two more leading national mass merchandisers this year, as we aggressively pursue the mass-market channel, which is responsible for more than 70 percent of the $30 billion yearly nutritional supplement sales in the U.S. We believe iSatori can replicate the success it has achieved in specialty retail and direct-to-consumer marketing within the mass-market sales channel, thereby creating the potential for much greater sales in the future.”
Non-GAAP Financial Measures
iSatori, Inc. has provided financial information in this release that has not been prepared in accordance with GAAP. This information includes non-GAAP adjusted net income (loss). iSatori uses such non-GAAP financial measures internally in analyzing its financial results and believes they are useful to investors, as a supplement to GAAP measures, in evaluating iSatori’s ongoing operational performance. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to evaluate ongoing operating results and trends, and in comparing its financial measures with other companies in iSatori’s industry, many of which present similar non-GAAP financial measures to investors. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures as detailed above.
| | |
Reconciliation of Gross Sales |
| First Quarter: March 31 |
| 2013 | 2012 |
Net Sales | $2,204 | $2,445 |
Add back returns, promotions, coupons, or other sales discounts | $715 | $351 |
Gross Sales | $2,919 | $2,796 |
About iSatori, Inc.
iSatori, Inc. is a consumer products firm that develops and sells nutritional products in the performance, weight-loss, and energy markets through online marketing,Fortune 500retailers, and thousands of retail stores around the world. More information about the Company is available atwww.iSatori.com.
The Company is headquartered in Golden, Colorado (Denver metropolitan area), and its common stock trades on the OTCQB market under the symbol “IFIT.”
Forward-Looking Statements
Statements made in this news release relating to the Company’s future sales, expenses, revenue, product developments, and all other statements except statements of historical fact, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on assumptions and estimates that management believes are reasonable based on currently available information; however, management’s assumptions and the Company’s future performance are both subject to a wide range of business risks and uncertainties, and there is no assurance that these goals and projections can or will be met. Any number of factors could cause actual results to differ materially from those in the forward-looking statements, including, but not limited to, the timing and extent of changes in demand for the Company’s products, the availability and price of ingredients necessary to manufacture such products, and the outcome of any current or future litigation regarding such products or similar products of competitors. All forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to update any such statement.
Contacts:
| |
iSatori, Inc. | R.J. Falkner & Company, Inc. |
Stephen Adele, 303-215-9174 | Jerry Falkner, 800-377-9893 |
PR@isatori.com | info@rjfalkner.com |
iSatori, Inc.
Condensed Consolidated Balance Sheets (Unaudited)
| | | | | |
| March 31, | | December 31, |
| 2013 | | 2012 |
ASSETS | | | | | |
Current assets: | | | | | |
Cash and cash equivalents | $ | 2,655,837 | | $ | 1,655,453 |
Investments | | - | | | 965,886 |
Accounts receivable | | | | | |
Trade, net of allowance for doubtful accounts | | 1,177,638 | | | 1,240,736 |
Income tax receivable | | 102,452 | | | 102,452 |
Other receivables - current portion | | 9,850 | | | 9,850 |
Inventories | | 1,360,729 | | | 1,292,105 |
Assets held for sale | | 83,823 | | | 29,338 |
Deferred tax asset, net | | 119,032 | | | 119,032 |
Prepaid expenses | | 119,621 | | | 156,431 |
Total current assets | | 5,628,982 | | | 5,571,283 |
| | | | | |
Property and equipment: | | | | | |
Leasehold improvements | | 7,928 | | | - |
Furniture and fixtures | | 81,620 | | | 56,680 |
Office equipment | | 65,901 | | | 36,600 |
Computer equipment | | 325,941 | | | 323,648 |
Dies and cylinders | | 49,422 | | | 49,422 |
Less accumulated depreciation | | (355,828) | | | (333,388) |
| | | | | |
Net property and equipment | | 174,984 | | | 132,962 |
| | | | | |
Note Receivable – net of current portion | | 81,714 | | | 81,714 |
| | | | | |
Other assets: | | | | | |
Deferred tax asset, net | | 97,844 | | | 97,844 |
Deposits and other assets | | 39,339 | | | 42,956 |
Debt Issuance Costs | | 2,500 | | | 4,375 |
Total other assets | | 139,683 | | | 145,175 |
Total assets | $ | 6,025,363 | | $ | 5,931,134 |
| | | | | |
LIABILITIES AND STOCKHOLDERS' EQUITY | | | | | |
Current liabilities: | | | | | |
Trade accounts payable | $ | 755,522 | | $ | 518,150 |
Accrued expenses | | 108,768 | | | 242,301 |
Line of credit, less debt discount | | 1,173,155 | | | 1,173,155 |
Current portion of notes payable | | 23,888 | | | - |
Total current liabilities | | 2,061,333 | | | 1,933,606 |
| | | | | |
Long-term liabilities | | | | | |
Derivative liability | | 880,696 | | | 701,852 |
Total long-term liabilities | | 880,696 | | | 701,852 |
| | | | | |
Commitments and contingencies (Notes 1,3 and 4) | | | | | |
iSatori, Inc.
Condensed Consolidated Balance Sheets (Unaudited)
(Continued)
| | | | | |
| March 31, | | December 31, |
| 2013 | | 2012 |
| | | | | |
Stockholders' Equity: | | | | | |
Convertible preferred stock, $0.01 par value, 750,000 shares authorized; 22,500 shares issued and outstanding ($450,000 of liquidation value) | | 225 | | | 225 |
Common stock, $0.01 par value, 56,250,000 shares authorized; 12,622,756 shares issued and outstanding | | 126,228 | | | 126,228 |
Additional paid-in capital | | 4,393,846 | | | 4,343,069 |
Accumulated deficit | | (1,436,965) | | | (1,173,846) |
Total stockholders’ equity | | 3,083,334 | | | 3,295,676 |
Total liabilities and stockholders' equity | $ | 6,025,363 | | $ | 5,931,134 |
iSatori, Inc.
Condensed Consolidated Statements of Operations (Unaudited)
| | | | | |
| March 31 | | March 31 |
| 2013 | | 2012 |
Revenues: | | | | | |
Product revenue (Net of returns and discounts) | $ | 2,203,856 | | $ | 2,445,407 |
Royalty revenue | | 32,710 | | | 30,581 |
Other revenue | | 19,800 | | | 23,729 |
Total revenue | | 2,256,366 | | | 2,499,717 |
| | | | | |
Cost of sales | | 1,045,113 | | | 951,028 |
Gross profit | | 1,211,253 | | | 1,548,689 |
| | | | | |
Operating Expenses: | | | | | |
Selling and marketing | | 316,175 | | | 473,679 |
Salaries and labor related expenses | | 534,328 | | | 480,536 |
Administration | | 416,447 | | | 279,796 |
Depreciation and amortization | | 25,016 | | | 17,828 |
Total operating expenses | | 1,291,966 | | | 1,251,839 |
| | | | | |
Income (loss) from operations | | (80,713) | | | 296,850 |
| | | | | |
Gain on sale of product lines | | - | | | 499,525 |
Other expense | | (124,359) | | | (16,080) |
Financing expense | | (46,761) | | | (50,603) |
Interest expense | | (1,152) | | | (62,089) |
| | | | | |
Income (loss) before income taxes | | (252,985) | | | 667,603 |
| | | | | |
Income tax expense | | (10,134) | | | (254,734) |
| | | | | |
Net income (loss) | $ | (263,119) | | $ | 412,869 |
| | | | | |
Net income (loss) per common share: | | | | | |
Basic | | (0.02) | | | 0.06 |
Diluted | | (0.02) | | | 0.06 |
| | | | | |
Weighted average shares outstanding: | | | | | |
Basic | | 12,622,756 | | | 6,841,293 |
Diluted | | 12,622,756 | | | 7,166,646 |
###
